Jo Nijs

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 16:55, April 16, 2018 by Kmdenmark (talk | contribs) (→‎Learn more: removed edit tag)
Source: ResearchGate

Jo Nijs, PT, MT, PhD, is an associate professor in Physiotherapy, Human Physiology, and Anatomy at Vrije Universiteit Brussel, Brussels, Belgium. He is a physiotherapist/manual therapist at the University Hospital Brussels, Brussels, Belgium and holder of the Chair 'Exercise immunology and chronic fatigue in health and disease' funded by the European College for Decongestive Lymphatic Therapy. He runs the international research group [www.paininmotion.be Our Pain in Motion] which studies the interactions between pain and body movement and focuses on central sensitization in various chronic pain disorders including fibromyalgia and chronic fatigue syndrome.[1][2]

Notable studies[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. https://www.researchgate.net/profile/Jo_Nijs
  2. https://www.wcpt.org/congress/speakers/Jo-Nijs
  3. Malfliet, A; Pas, R; Brouns, R; De Win, J; Hatem, SM; Meeus, M; Ickmans, K; van Hooff, RJ; Nijs, J (2018), "Cerebral Blood Flow and Heart Rate Variability in Chronic Fatigue Syndrome: A Randomized Cross-Over Study", Pain Physician, 21 (1): E13-E24
  4. Polli, Andrea; Willekens, Barbara; Meeus, Mira; Nijs, Jo; Collin, Simon M.; Ickmans, Kelly (2017), "Endogenous Pain Facilitation Rather Than Inhibition Differs Between People with Chronic Fatigue Syndrome, Multiple Sclerosis, and Controls: An Observational Study Observational Study", Pain Physician, 20 (4): E489-E497, PMID 28535557
  5. Nijs, J; Danneels, L; Lambrecht, L; Moorkens, G; Meeus, M; Paul, L; Van Oosterwijck, J; Marusic, U; De Wandele, I (2017), "The Role of Autonomic Function in Exercise-induced Endogenous Analgesia: A Case-control Study in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Healthy People", Pain Physician, 20 (3): E389-E399, PMID 28339438
  6. Nijs, J; Malfliet, A (2016), "Rehabilitation for patients with myalgic encephalomyelitis/chronic fatigue syndrome: time to extent the boundaries of this field", Journal of Intern Medicine, 279 (3): 265-7, doi:10.1111/joim.12431
  7. Nijs, J; Nees, A; Paul, L; De Kooning, M; Ickmans, K; Meeus, M; Van Oosterwijck, J (2014), "Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: a systematic literature review", Exercise Immunology Review, 2014 (20): 94-116, PMID 24974723
  8. Meeus, M; Nijs, J; Hermans, L; Goubert, D; Calders, P (September 2013), "The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets?", Expert Opin Ther Targets, doi:10.1517/14728222.2013.818657, PMID 23834645
  9. Goudsmit, Ellen M; Nijs, Jo; Jason, Leonard A; Wallman, Karen E (2012), "Pacing as a strategy to improve energy management in myalgic encephalomyelitis/chronic fatigue syndrome: a consensus document", Disability and Rehabilitation, 34 (13): 1140-7, doi:10.3109/09638288.2011.635746
  10. Jo Nijs & Garth L. Nicolson. (2004). Gulf War Veterans: Evidence for Chromosome Alterations and Their Significance. Journal of Chronic Fatigue Syndrome, Vol. 12, Iss. 1, pp. 79-83. http://dx.doi.org/10.1300/J092v12n01_06
  11. Jo Nijs, Kenny De Meirleir, Danny Coomans, Pascale De Becker & Garth L. Nicolson. (2003). Deregulation of the 2,5A Synthetase RNase L Antiviral Pathway by Mycoplasma spp. in Subsets of Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 11, Iss. 2, pp. 37-50. http://dx.doi.org/10.1300/J092v11n02_04
  12. Nijs J, Nicolson GL, De Becker P, Coomans D, De Meirleir K. (2002). High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients. FEMS Immunology and Medical Microbiology, 34(3):209-14. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12423773